medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 5

<< Back Next >>

Acta Pediatr Mex 2023; 44 (5)

Principles and quality indicators of newborn screening

Vela AM
Full text How to cite this article

Language: Spanish
References: 23
Page: 408-414
PDF size: 235.27 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Hall K. Max Wilson and the Principles and Practice ofScreening for Disease. Int J Neonatal Screen 2020; 6 (1):15. doi: 10.3390/ijns6010015.

  2. Wilson JMG, Jungner G. Principles and Practice of Screeningfor Disease. WHO papers No 34; 1968. https://niercheck.nl/wp-content/uploads/2019/06/Wilson-Jungner-1968.pdf.

  3. Andermann A, Blancquaert I, Beauchamp S, Déry V. RevisitingWilson and Jungner in the genomic age: A review ofscreening criteria over the past 40 years. Bull. World HealthOrgan 2008; 86: 317-319. doi: 10.2471/BLT.07.050112.

  4. Breslow L. An historical review of multiphasic screening.Prev Med 1973; 2 (2): 177-96. doi: 10.1016/0091-7435(73)90063-7. PMID: 4579344.

  5. Guthrie R, Susi A. A Simple Phenylalanine Method for DetectingPhenylketonuria in Large Populations of NewbornInfants. Pediatrics 1963; 32: 338-43.

  6. Centers for Disease Control and Prevention (CDC). Ten greatpublic health achievements--United States, 2001-2010.MMWR Morb Mortal Wkly Rep 2011; 60 (19): 619-23.

  7. Centers for Disease Control and Prevention (CDC). CDCGrand Rounds: Newborn screening and improved outcomes.MMWR Morb Mortal Wkly Rep 2012; 61 (21): 390-3.

  8. Darby E, Thompson J, Johnson C, Singh S, et al. Establishinga National Community of Practice for Newborn ScreeningFollow-Up. Int J Neonatal Screen 2021; 7 (3): 49. doi:10.3390/ijns7030049.

  9. Association of Public Health Laboratories (APHL). Thenewborn screening story: How one simple test changedlives, science, and health in America. http://www.aphl.org/aboutAPHL/publications/Documents/NBS_2013May_The-Newborn-Screening-Story_How-One-Simple-Test-Changed-Lives-Science-and-Health-in-America.pdf

  10. Vela-Amieva M, Espino-Vela J. Tamiz neonatal para detectarcardiopatías congénitas complejas. La nueva revolución enpediatría. Acta Pediatr Mex 2013; 34: 237-240.

  11. Juárez-Echenique JC. Tamizado oftalmológico neonatal.Acta Pediatr Mex 2015; 36: 361-363.

  12. American Academy of Pediatrics; Committee on Practiceand Ambulatory Medicine, Section on Ophthalmology;American Association of Certified Orthopedists; AmericanAssociation for Pediatric Ophthalmology and Strabismus;American Academy of Ophthalmology. Eye examinationin infants, children, and young adults by pediatricians.Pediatrics 2003; 111 (4): 902-907.

  13. Urueta CP. El tamiz visual: mostrando el mundo al reciénnacido. Rev CONAMED. 2023; 28(1): 22-36. https://dx.doi.org/10.35366/110869.

  14. Diagnóstico y tratamiento oportuno de la displasia deldesarrollo de la cadera. Evidencias y recomendaciones.Guía de Práctica Clínica S-091-08. https://www.imss.gob.mx/sites/all/statics/guiasclinicas/091GRR.pdf

  15. Reyes-Cerecedo A, Flores-Calderón J, Villasis-Keever MA,Chávez-Barrera JA, et al. Uso de la tarjeta colorimétricavisual para la detección oportuna de atresia de vías biliares.Bol Med Hosp Infant Mex 2018; 75 (3): 160-165.

  16. Yusuf C, Sontag MK, Miller J, Kellar-Guenther Y, et al. Developmentof National Newborn Screening Quality Indicatorsin the United States. Int J Neonatal Screen 2019; 5 (3): 34.doi: 10.3390/ijns5030034.

  17. Ojodu J, Singh S, Kellar-Guenther Y, Yusuf C, et al. NewSTEPs:The Establishment of a National Newborn ScreeningTechnical Assistance Resource Center. Int J Neonatal Screen2017; 4 (1): 1. doi: 10.3390/ijns4010001.

  18. World Health Organization. Advisory Committee onHealth Research. Genomics and world health report ofthe Advisory Committee on Health Research. World HealthOrganization, Geneva; 2002.

  19. International Bioethics Committee. Report of the InternationalBioethics Committee (IBC) on Updating Its Reflectionon the Human Genome and Human Rights. Final recommendations.Rev Derecho Genoma Hum 2015; (43): 195-9.

  20. Pullman D, Etchegary H. Ethical, Legal, and Social Issues(ELSI) in Clinical Genetics Research. Methods Mol Biol2021; 2249: 65-82. doi: 10.1007/978-1-0716-1138-8_5.

  21. Ascencio-Carbajal T, Saruwatari-Zavala G, Navarro-GarciaF, Frixione E. Genetic/genomic testing: defining the parametersfor ethical, legal and social implications (ELSI).BMC Med Ethics 2021; 22 (1): 156. doi: 10.1186/s12910-021-00720-5.

  22. Advisory Committee on Heritable Disorders in Newbornesand Childrens. Recomended uniform screening panel.HRSA. 2023. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp (acceso 23 de julio de 2023).

  23. Omari A, Reeves SL, Prosser LA, Creary MS, et al. Usabilityof NewSTEPs Data for Assessing the Characteristics ofInfants with Newborn Screening Disorders. Int J NeonatalScreen 2022; 8 (3): 42. doi: 10.3390/ijns8030042.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2023;44